Study of a Monoclonal Antibody and Ketoconazole in Patients with Prostate Cancer
Number: NCT00859781 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Weill Medical College of Cornell University Sponsor Trial Information Trial Location(s) and Contact(s)
Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy
RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)
Number: NCT02090114 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s)
Use of Ligand-Inducible Autologous T Cells Engineered to Target PSCA on Tumor Cells in Selected Advanced Solid Tumors
Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer
Number: NCT03800784 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2/3 Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Sponsor Trial Information Trial Location(s) and Contact(s)
Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer
Number: NCT03999515 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of Washington|National Cancer Institute (NCI)|Janssen Research & Development, LLC Sponsor Trial Information Trial Location(s) and Contact(s)
An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancer
Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC)